A recent study has made significant progress in uncovering the microscopic mechanism behind heavy-ion cancer therapy, which ...

William Blair lifted their Q1 2026 earnings estimates for shares of Ionis Pharmaceuticals in a research note issued on ...

Ionis Pharmaceuticals IONS signed a license agreement with Japan-based Ono Pharmaceutical. Per the terms, Ono has acquired ...

William Blair analyst Myles Minter reiterated a Buy rating on Ionis Pharmaceuticals (IONS – Research Report) today. The company’s shares opened ...

Arizona State Retirement System raised its position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 8.8% in the ...

Ionis Pharmaceuticals (IONS) and Ono Pharmaceutical announced that the two companies have entered into a license agreement in which Ono obtains ...

Assembling DNA nanostructures at more moderate temperatures opens up the possibility of using the structures in biomedical ...

Researchers have confirmed that mammalian BK ion channels regulate themselves using a “ball-and-chain” mechanism. A recent ...